OTC Pharmaceuticals - Denmark

  • Denmark
  • Revenue in the OTC Pharmaceuticals market amounts to US$189.70m in 2024. The market is expected to grow annually by 2.56% (CAGR 2024-2029).
  • The market's largest segment is the segment Other OTC Pharmaceuticals with a market volume of US$68.92m in 2024.
  • In global comparison, most revenue is generated in the United States (US$41,240m in 2024).
  • In relation to total population figures, per person revenues of US$31.94 are generated in 2024.
  • In the OTC Pharmaceuticals market, 17.8% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

Region comparison

Analyst Opinion

The OTC Pharmaceuticals market in Denmark is experiencing steady growth due to several factors. Customer preferences for self-medication and convenience have contributed to the increasing demand for over-the-counter drugs. Additionally, local special circumstances and underlying macroeconomic factors have also played a role in shaping the market.

Customer preferences:
In Denmark, there is a growing trend towards self-care and self-medication. Consumers are increasingly seeking out over-the-counter pharmaceuticals to treat common ailments and minor health issues. This preference for self-medication is driven by the convenience and accessibility of over-the-counter drugs. Consumers appreciate the ability to purchase these products without a prescription, saving them time and money. Furthermore, the increasing availability of information online has empowered consumers to make informed decisions about their healthcare, leading to a greater reliance on over-the-counter medications.

Trends in the market:
One of the prominent trends in the OTC Pharmaceuticals market in Denmark is the rising demand for natural and herbal remedies. Consumers are increasingly seeking out products that are perceived to be more natural and have fewer side effects. This trend is in line with the global shift towards natural and holistic healthcare solutions. As a result, there has been an increase in the availability and variety of natural and herbal over-the-counter pharmaceuticals in the Danish market. Another trend in the market is the growing focus on preventive healthcare. Consumers are becoming more proactive in managing their health and are seeking products that can help them prevent illnesses and maintain overall well-being. This trend has led to an increase in the demand for over-the-counter vitamins, supplements, and other preventive healthcare products. Manufacturers are responding to this demand by introducing new products and formulations that cater to the growing interest in preventive healthcare.

Local special circumstances:
Denmark has a well-developed healthcare system with a strong emphasis on public health. This focus on public health has led to a high level of health awareness among the population. The Danish government actively promotes preventive healthcare and encourages individuals to take responsibility for their own health. This cultural emphasis on health and wellness has created a favorable environment for the OTC Pharmaceuticals market to thrive.

Underlying macroeconomic factors:
Denmark has a stable and prosperous economy, which has contributed to the growth of the OTC Pharmaceuticals market. The country has a high standard of living and a well-educated population, which has led to increased healthcare spending. Additionally, Denmark has a strong pharmaceutical industry, with several domestic and international companies operating in the market. This competitive landscape has fostered innovation and product development, further driving the growth of the OTC Pharmaceuticals market. In conclusion, the OTC Pharmaceuticals market in Denmark is experiencing growth due to customer preferences for self-medication and convenience, as well as the local special circumstances and underlying macroeconomic factors. The increasing demand for natural and herbal remedies and the focus on preventive healthcare are key trends shaping the market. With a strong emphasis on public health and a stable economy, Denmark provides a favorable environment for the OTC Pharmaceuticals market to thrive.


Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.


In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.


  • Revenue
  • Key Players
  • Analyst Opinion
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait


Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)